Forbes has put out its annual Midas List ranking VCs and life sciences and the Bay Area is represented.
An excerpt from “New Names On The 2015 Midas List”:
“A Healthy Dose of Life Sciences
After a lengthy battle with heavy industry regulations and disappointing public offerings, the life science sector bounced back this year with two new Midas Listers. At #91, and one of TrueBridge’s identified Top Life Science Investors of 2014, Dr. Beth Seidenberg of KPCB hit gold with Flexus Biosciences, acquired by Bristol-Myers Squibb after its incubation in Kleiner Perkins’ offices.”